In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo - FiercePharma

Submitted by Anonymous (not verified) on Wed, 05/10/2023 - 15:25

In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo  FiercePharma